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A B S T R A C T
Our study evaluated red blood cell count as supporting hematological index to hematocrit level in predicting
severe malarial anemia instead of the hemoglobin levels among malaria-infected children in Ghana. This case-
control study was conducted at the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. The study
recruited 139 children, of which 45 were Controls (C), 43 with severe malaria (SM), and 51 with mild malaria
(MM). Validated questionnaires were administered to obtain the socio-demographic data from each respondent.
Venous blood was obtained for parasitemia count and to determine the hematological profile of each participant.
With point of observation, data analysis was done. The mean age of the children was 4.22  2.65 years. Median
levels of hemoglobin (Hb) decreased in the order; C > MM > SM (P < 0.0001). There was a reduction in median
levels of hematocrit (HCT) (P < 0.0001), RBC (red blood cells count) (<0.0001), from the MM to the SM. Among
patients with severe malaria, there were a positive significant spearmen's co-efficient correlations between me-
dian levels of RBC (r ¼ 0.652, P ¼ 0.005) and HB (r ¼ 0.640, P ¼ 0.006) individually against HCT. However
among the mild malaria patients only RBC (r ¼ 0.884, P < 0.001) was positively correlated against HCT. At a cut-
off of <4.0106/uL for RBC and <8.8 g/dL for Hb, RBC (90.4%) recorded a slightly high accuracy in predicting
severe falciparum malarial anemia than Hb (86.9%) among the cases. Red blood cell count may be a promising
indicator to support hematocrit (<15%) in defining severe malarial anemia than hemoglobin level (<5 g/dL)
among malaria-infected children from endemic areas in Ghana.
1. Introduction
Malaria is one of the most common infectious diseases in the world
and one of the greatest global public health problems [1], mostly among
children under 5 years [2]. About 90% of the world's severe and fatal
malaria is projected to affect young children in sub-Saharan Africa [3], as
major complications of severe falciparum malaria (SFM) develop rapidly
and progress to death within hours or days [4]. Exposure of the signs of
severe malaria and acting accordingly play significant roles in abating the
increasing mortality rate. However, because these signs lack specificity,
as there is no ‘‘gold standard’’ methodology to identify individuals with
‘‘true’’ severe malaria other than mostly severe anemia with higher
microscopic parasitemia observed among patients [5]. The WHO clas-
sifies SFM as P. falciparum asexual parasitemia and no other confirmed
cause for their symptoms or signs and with the presence of one or more of
the clinical features (Cerebral malaria, pulmonary edema, acute renal
failure, severe anemia, metabolic acidosis, multiple convulsions, pros-
tration, jaundice, significant bleeding, hypoglycemia, and shock) [4].
Studies have shown that hematological changes such as low red blood
cell count, hemoglobin (Hb) level, and hematocrit are amongst the most
common complications of malaria and are involved in the pathology of
the disease [6,7]. From the WHO (2014) report, anemia associated with
SFM among children under 12 years is defined as Hb < 5 g/dl or he-
matocrit <15%. Confirmation of severe malarial anemia using these
parameters is not substantial as the estimation of Hb levels, is accom-
panied by numerous setbacks including variables due to differing malaria
endemicity, background hemoglobinopathy, nutritional status, de-
mographic factors, and malaria immunity especially in the tropics [8,9].
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This is likely to be the scenario with changing epidemiology and misdi-
agnosis of severe falciparum malarial anemia in Africa as there are many
other causes of low Hb levels such as with bacteremia, HIV-1, and
hookworm infections [10,11] as well as chronic transmission of malaria
in holoendemic regions.
Although parasite-driven hemolysis contributes to a reduction in Hb
levels in childhood malaria, one of the primary mechanisms responsible
for low Hb levels in children with severe malaria anemia is impaired or
ineffective erythropoiesis [12]. It is important to note that some or all of
these factors can culminate in chronically low Hb levels observed in in-
fants and young children residing in holoendemic regions. As such, the
degree of Hb is typically a poor indicator of severe malarial anemia in
these settings [12], warranting the exploration of additional markers to
enhance prompt detection and accurate classification.
High levels of parasitemia, particularly in non-immune individuals,
can result in massive lysis and clearance of RBCs, resulting in profound
anemia [13]. Acute malaria can cause severe anemia due to hemolysis of
infected and uninfected RBCs, and chronic or subclinical malaria can
induce anemia due to inflammation. Based on this premise, we postulate
that red blood cell count could serve as a supportive indicator in pre-
dicting severe falciparum malarial anemia (<15% hematocrit) among
children.
2. Materials and methods
2.1. Study design/study site
This hospital-based case-control study was carried out at the Komfo
Anokye Teaching hospital (KATH), Kumasi, Ghana. Ghana is geograph-
ically placed near the equator and lies between Latitude: 7 570 9.9700 N
and Longitude: -1 010 50.5600 W, with more than 30 million people ac-
counting for about 2.5% of African's population (Ghana Statistical Ser-
vice, 2010 Population and Housing Census). Kumasi is the regional
capital of the Ashanti region with an estimated population of 4,780,380
(Ghana Statistical Service, 2010). KATH is a major Teaching Hospital and
it is positioned in the middle belt of Ghana. It has over 1000 bed capacity.
The relatively good road network and the cosmopolitan nature of Kumasi
make the hospital accessible to all other areas. Kumasi is a malaria-
endemic zone in Ghana.
2.2. Study population and sample size calculation
All children below the age of twelve years with symptoms of malaria
(malaria suspects) who reported to the child health departments of KATH
were screened for malaria. Children with or co-morbid with Human
Immunodeficiency Virus (HIV), enteric fever, sickle cell disease and
hepatitis B and C infections, and pyrexia of unknown origin were
excluded from the study. Children who visited the hospital and tested
negative for falciparum malaria were recruited as “Controls” using the
microscopic test as diagnosis [14].
The World Health Organization (2014) defines severe falciparum
malaria in children as the presence of P. falciparum but no other
confirmed cause for signs and symptoms and vital organ dysfunction with
clinical features such as impaired consciousness, prostration, multiple
convulsions, acidotic breathing, acute pulmonary edema, and acute res-
piratory distress, shock, acute kidney injury, and or clinical jaundice plus
one or more of laboratory findings such as hypoglycemia (less than 2.2
mmol/L), metabolic acidosis (plasma bicarbonate less than 5 g/dl), se-
vere normocytic anemia (less than 5 g/dl and packed cell volume less
than 15%), hemoglobinuria, hyperlactatemia (greater than 5 mmol/L),
pulmonary edema (radiological) and renal impairment (serum creatinine
greater than 265 μmol/L). Modifications were made where necessary to
suit this study.
In this study, severe falciparum malaria was defined as the presence
of P. falciparum asexual parasitemia with severe grade (>100,000/uL)
[15] in the presence of an identified cause; a hematocrit of less than 15%
in children below 12 years of age regardless of the hemoglobin levels and
present with one or more symptoms of malaria [16]. Patients who pre-
sent with and a positive parasitological test (microscopy) and mild grade
of parasitemia (1–99999/uL) [15] but had no features of severe malaria
was defined as having mild malaria.
Following the method of Charan and Bisways (2013) [17], a sample
size of 140 malaria patients was proposed for the study. This research
targeted 5%–10% of the population in the study area. After computing,
the sample size was 140 children for 5% and 280 children for 10% of the
population. At the end of the study 139 study participants were recruited
in a 1:2 control-case ratio. Out of the total participants, 45 controls and
94 were cases comprising 43 and 51 been described as patients with
severe malaria and mild malaria respectively.
2.3. Ethical considerations
Ethical clearance for the study was obtained from the Committee on
Human Research, Publication, and Ethics (CHRPE) at the KNUST School
of Medical Sciences/Komfo Anokye Teaching Hospital in Kumasi-Ghana
(Reference Number: CHRPE/AP/078/17). Permission was also given by
the various Medical Directors/Superintendents or Heads of Departments
of the child health departments. Written informed consent was also ob-
tained from healthcare personnel and guardians of study participants
were adequately informed of the procedures, nature, risk, and the pur-
pose of the study. Parents of qualified patients were invited to participate
in the study and requested to fill or thumbprint a consent form with the
help of the research team before their wards were recruited for the study
according to the Helsinki declaration [18].
2.4. Questionnaire
A validated questionnaire was used to obtain socio-demographic data
of the study participants from their guardians. Other clinically relevant
information was obtained from the hospital archives.
2.5. Sample analysis
Three milliliters of the venous blood sample was collected from each
participant and dispensed into K2 EDTA tubes for hematological analysis
and the assessment of malaria parasite density. Standard thick and thin
films were prepared on clean grease-free slides. Thin films fixed with
absolute methanol. Both thick and thin smears were stained, 10%Giemsa
and examination for malaria parasite by light microscopy. Malaria
parasite was identified by observation of the smears and the morpho-
logical appearance of the parasite in the infected red blood cells (RBCs)
using a 100 microscope objective.
Full blood count was determined using an automated hematological
analyzer (Sysmex Automated Hematology Analyzer, Kobe, Japan, XP-
300). From the World Health Organization (WHO, 2005) children are
considered to be anemic at Hb level less than 11 g/dL [16].
Parasite load was calculated after counting asexual parasites per 200
white blood cells (WBC), assuming mean WBC count of 8000 count/μL
using the following formula:
Parasite load=μL¼Number of observed asexual parasites8000WBCcount=μL
200WBCs
The degree of parasitemia was graded as mild and severe when a
count (x) is from 1 to 99,999/μL and>100,000/μL, parasites respectively
[15].
2.6. Data analysis
Data were entered into Microsoft Excel 2013 and cleaned before
being subjected to analysis. Statistical analyses were performed using
GraphPad Prism 6, R statistical software, and IBM- SPSS version 20.0.
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Medians were calculated for continuous variables such as the hemato-
logical parameters and Kruskal-Wallis used to compare more than two
median levels of variables of continuous variables and was presented in
the violin plot (R statistical software). While percentages were calculated
for categorical variables data and presentation of socio-demographics
and prevalence of anemia were done by using tables and bar graphs
respectively. Unpaired t-test was used to compare two means of contin-
uous variables such as the age of participants. Receiver operating char-
acteristics (ROC) curve analyses were used for depicting the diagnostic
performance of red blood cell count and hemoglobin for hematocrit as an
indicator of severe malarial anemia. A p-value < 0.05 was considered
statistically significant.
3. Results
The mean age (SD) of all the children was 4.22 (2.65) years. The
mean age of those with mild and severe malaria was 4.32 (2.81)years
and 4.27 (2.96)years respectively. A higher proportion of the study
participants (67.5%) were within the age of 0–5 years. Alaxin and Lonart
were the widely used anti-malarial drugs among non-severe patients,
while Artemether was the predominant medication among severe ma-
laria patients (58.3%) (Table 1).
Median levels of HCT decreased significantly in the order; control >
mild malaria > severe malaria. There were statistically significant dif-
ferences in the Median levels of Red blood cell (RBC), Hemoglobin (Hb),
Table 1. Socio-demographic characteristics of study participants.
Variables Control
(n ¼ 45)
Mild malaria (n ¼ 51) Severe malaria (n ¼ 43) P-value
Age (years) (mean ± SD) 3.80  1.66 4.32  2.81 4.27  2.96 0.309
The age range of the wards (years)
0–5 30 (32.3%) 35 (37.6%) 28 (30.1%) 0.9363
6–10 15 (34.1%) 14 (%31.8%) 15 (34.1%) 0.7109
11–12 - 2 (100.0%) - NA
Gender
Male 24 (36.4%) 24 (36.4%) 18 (27.2%) 0.5581
Female 21 (28.8%) 27 (37.0%) 25 (34.2%) 0.5581
Medication
Alaxin - 13 (100.0%) - NA
Artesunate - 3 (60.0%) 2 (40.0%) 0.7910
Artemether - 5 (41.7%) 7 (58.3%) 0.3487
Artesunate Amodiaquine - 24 (63.2%) 14 (36.8%) 0.1535
Lonart - 2 (100.0%) - NA
P-value<0.05 ¼ statistically significant, SD ¼ Standard Deviation, NA ¼ Not Applicable.
Figure 1. Comparison of hematological parameters between controls, mild and severe malaria. C¼Controls, MM ¼ Mild Malaria cases, SM ¼ Severe Malaria cases,
Significant differences in median levels; * ¼ P < 0.05, ** ¼ P < 0.01, *** ¼ P < 0.001.
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Mean corpuscular hemoglobin concentration (MCHC), and Platelet count
(PLT) across the various study groups. Median levels of Mean corpuscular
hemoglobin (MCH) was higher among the controls than the mild and
severe malaria cases. Also, median White blood cell count (WBC)
increased significantly in the order; control < mild malaria < severe
malaria. There was no significant difference for Mean corpuscular vol-
ume (MCV) (Figure 1).
For patients with mild malaria, 30 out of 51 were anemic, while all
the patients with severe malaria were anemic. There were significant
differences in the prevalence of anemia between the controls and cases
(Figure 2).
Among patients with severe malaria, there were a positive significant
spearmen's co-efficient correlations between median levels of RBC (r ¼
0.652, P ¼ 0.005) and HB (r ¼ 0.640, P ¼ 0.006) individually against
HCT. However among the mild malaria patients only RBC (r¼ 0.884, P<
0.001) was positively correlated against HCT. There was a positive cor-
relation between age and MCV, MCH and MCHC among the severe ma-
laria cases while age was positively correlated with MCH only in the mild
malaria cases (Table 2).
Using a cut-off of <4.0106/uL, RBC had a sensitivity of 100.0% and
specificity of 83.17%, with negative predictive value (NPV) of 100.0%
and positive predictive value (PPV) 79.63%. A Hb cut-off of <8.8 g/dL,
however, yielded a sensitivity, specificity, PPV and NPV of 90.70%,
90.24%, 90.70%, and 90.24% respectively differentiate mild and severe
malaria with a marginally lower agreement (kappa) compared to the RBC
cut-off of 4.0106/uL. Conversely, using the receiver operating charac-
teristics (ROC) curve analyses, the area under the curve (AUC) for RBC
(93.42%) was higher than that for Hb (92.75%) (Table 3 and Figure 3).
Figure 2. Prevalence of anemia among the study population. Significant dif-
ferences in proportions; ** ¼ P < 0.01, *** ¼ P < 0.001.
Table 2. Correlation between age, hematological parameters in mild and severe malaria cases.
Parameters Age Hb RBC HCT MCV MCH MCHC PLT
Age r 0.134 -0.290 0.015 0.527 0.524 0.450 0.282
p-value 0.392 0.059 0.923 <0.001 <0.001 0.002 0.106
Hb r 0.012 0.628 0.640 -0.067 0.134 0.360 0.573
p-value 0.932 0.007 0.006 0.797 0.609 0.156 0.041
RBC r -0.228 0.107 0.652 -0.717 -0.607 -0.403 0.194
p-value 0.152 0.966 0.005 0.001 0.010 0.109 0.525
HCT r -0.158 0.222 0.884 -0.191 -0.194 -0.165 0.014
p-value 0.325 0.163 <0.001 0.463 0.457 0.528 0.964
MCV r 0.172 0.404 -0.203 0.266 0.909 0.639 -0.140
p-value 0.281 0.009 0.203 0.092 <0.001 0.006 0.649
MCH r 0.318 0.581 -0.764 -0.493 0.525 0.890 0.115
p-value 0.043 <0.001 <0.001 <0.001 <0.001 <0.001 0.709
MCHC r 0.238 0.413 0.731 -0.737 -0.088 0.788 0.436
p-value 0.134 0.007 <0.001 <0.001 0.586 <0.001 0.136
PLT r 0.077 0.217 -0.043 -0.307 -0.351 0.303 0.775
p-value 0.651 0.197 0.807 0.077 0.042 0.081 <0.001
P-value<0.05 ¼ statistically significant, r ¼ Pearson co-efficient, Italic ¼ Severe cases, Non-italic ¼Mild cases, Hb ¼ Hemoglobin, RBC ¼ Red blood cell count, HCT ¼
Hematocrit, MCV ¼ Mean corpuscular volume, MCH ¼ Mean cell hemoglobin, MCHC ¼ Mean corpuscular hemoglobin concentration, PLT ¼ Platelet count, WBC ¼
White blood cell count.
i) The italic style defines the medians of the severe cases variables. ii) The bold style of P-values of some variables depicts the rective medians been statistically sig-
nificant (ie. when the p-value is less tham 0.05).
Table 3. Diagnostic yield of the combined performance of hemoglobin level and
parasite count, and the combined performance of red blood cell count and
parasite count as possible indicators to differentiate mild and severe malaria
cases.
Hb (g/dL) RBC(106/uL) Hb*(g/dL)
Cut-off point 8.8 4 5
Sensitivity % 90.7 100 13.95
(95%CI) (77.69–96.77) (89.97–100.0) (6.28–27.77)
Specificity % 90.24 83.17 100.0
(95%CI) (76.73–96.60) (67.87–94.35) (89.73–100.0)
PPV% 90.70 79.63 100.0
NPV% 90.24 100.0 52.55
LRþ 9.3 3.7 -
LR- 0.1 0 0.9
TP 39 43 6
TN 34 30 41
FP 4 11 0
FN 4 0 37
Accuracy % 86.9 90.4 55.95
AUC % 92.75** 93.42** -
Kappa value 0.701** 0.766** 0.101
** ¼ P-value<0.01 ¼ statistically significant, PPV ¼ Positive Predictive Value,
NPV¼ Negative Predictive Value, CI-Confidence Interval, LR¼ Likelihood Ratio,
TP ¼ True Positives, TN- True Negatives, FP ¼ False Positives. FN ¼ False
Negatives.
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4. Discussion
This present study demonstrates a degree of variation in hematolog-
ical parameters in response to malaria infection. There was a marked
decrease in Hb, RBC, HCT, and PLT measurements among patients pre-
senting with severe malaria than mild malaria [19]. This may be
explained by the prompt pathophysiology of malaria following the
erythrocytic cycle highlights the diagnostic value of hematological al-
terations in malaria-endemic areas [20]. The characteristic pattern of
percentage parasitized RBC (hyper parasitemia), with consequent ane-
mia and other hematological variations were observed in this study. A
study conducted in Kenya by Maina et al. revealed similar variations in
the hematological measures and is therefore in harmony with the find-
ings in the current study [6].
In this study, the majority of the study participants were within 0–5
years of age (Table 1). This observation agrees with several reports that
malaria usually affects children below 5 years, especially in areas of
intense transmission like Kumasi where the study was conducted [21].
Underdeveloped immunity has been the major explanation for this
experience [6].
This study also shows that anemia is associated with the severity of
malaria infection.Median levels of hematocrit (HCT)decreasedsignificantly
in theorder; control>mildmalaria> severemalaria.Therewasa significant
reduction in median levels of Hb RBC, MCHC, and PLT in the order: mild
malaria> severemalaria (Figure 1). A similar trend of these results was also
found in a study by Maina et al. in western Kenya. They concluded that
infection with P. falciparum results in significant changes in hematological
parameters of children living in malaria-endemic regions, and the most
commonly affected parameters are hematocrit, hemoglobin, absolute
monocyte counts and RBCs [6]. Hematocrit levels decrease as RBC, Hb, and
PLT decrease [22], and the overall effects were observed in this study. Also
consistent with our study findings is a review by Perkins et al. [23].
Although reduced RBC and PLT have been associated with malaria
prevalence has been established [8], it has not been acknowledged in
most health care settings as part of the significant diagnostic markers to
determine the extent and severity of the condition, partly they are not
routinely obtained at malaria clinics [6].
Among patients with severe malaria, there were positive significant
spearmen's co-efficient correlations between RBC (r ¼ 0.652, P ¼ 0.005)
and HB (r ¼ 0.640, P ¼ 0.006) individually against HCT in this study.
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Figure 3. Receiver operating characteristics (ROC) curve analyses for depicting the overall combined diagnostic performance of hemoglobin level and parasite count,
and red blood cell and parasite count in differentiating mild and severe malaria cases.
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However among themildmalaria patients only RBC (r¼ 0.884, P< 0.001)
was positively correlated against HCT (Table 2). This finding was disso-
nancewitha studybyLee et al. [21],where therewasa stronger relationship
between Hb and HCT in Plasmodium falciparum malaria [24]. Other re-
ports, however, indicate that, at higher levels of parasitemia, excessive
hemolysis of parasitized RBCs may lead to anemia, thus having a direct
effect on the HCT [25]. This may be the reason for the higher predictive
power for RBC thanHb in this present study. In this study.Nevertheless, the
density of Plasmodiumparasitemia identified in this study didnot influence
Hb levels and this is in parallel to study Ehrhardt et al. on a topic “Malaria,
Anemia, and Malnutrition in African Children” (2006) [26].
The WHO recommends the use of Hb (<5.0 g/dL) in the classification
of mild and severe malaria cases in children under 12 years [16]. None-
theless, aHbcut-off of 5 g/dl presentedwithpoor predictive power against
HCT (<15%) with a severe grade of parasitemia in defining severe fal-
ciparum malarial anemia in this study. This finding buttresses the signif-
icant influence of demography and its accompanying factors on various
disease profiles of severe malaria as just hemoglobin level may be less
sufficient to indicate severemalarial anemia [27]. Interestingly, however,
at cut-offs of <4.0106/uL and <8.8 g/dL for RBC and Hb with respec-
tively, RBC and Hb* shown a high diagnostic yield accuracy differenti-
atingmild and severemalaria.Moreover, Hb displaced a lessermeasure of
agreement (kappa) than RBC in predicting the severe malarial anemia
(hematocrit<15%). Using the receiver operating characteristics (ROC)
curve analyses, RBC recorded a slightly higher area under curve (AUC)
value than Hb. Thus, RBC was able to predict true severe malarial anemia
cases than Hb. This current study is in harmony with the findings of Car-
neiro et al. [24] who found inconsistency in using hemoglobin (5 g/dL) as
the direct threefold reduced conversion of hematocrit in assessing anemia
in malaria-endemic settings. They found out there was inconsistency in
using hemoglobin (<5g/dL) as a direct three-fold reduced-conversion of
hematocrit (<15%) in defining severe malarial anemia in Africa. Collec-
tively, our studyfindings suggest that the use of<5 g/dLhemoglobin as an
indicator for anemia with asexual falciparum parasitemia to differentiate
mild and severe malaria among Ghanaian children on antimalarial regi-
mens such as Artesunate Amodiaquine as may not be appropriate, how-
ever, RBC count of <4.0106/uL may be more reliable.
Nonetheless, it is worthy of note that this study is limited by the
relatively small sample size. Thus, a larger sample size should be
considered in further studies. Also, multi-hospital study sites should be
adopted in further studies, and assessment of dietary intakes such as iron-
containing foods and products should be taken into consideration to
provide some initial insights.
5. Conclusion
Red blood cell count in combination with high parasitemia and HCT
in children from malaria-endemic areas may be useful as a generic sup-
portive diagnostic criterion for the classification of severe and mild
malaria in children on antimalarial regimens from malaria-endemic
areas. New strategic interventions may be adopted in diagnosing chil-
dren with severe malarial anemia in developing countries such as Ghana.
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